If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

PDMR Dealing

24 Apr 2018 17:04

RNS Number : 9918L
Omega Diagnostics Group PLC
24 April 2018
 

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

PDMR Dealing

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 24 April 2018 that Edward Valente, Group R&D Director of the Company has purchased 124,044 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a price of 14.5 pence per Ordinary Share.

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Edward Valente

2.

Reason for notification

b)

Position / status

Group R&D Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Purchase of Ordinary Shares

 GB00B1VCP282

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Volume(s)

Price(s) ÂŁ

124,044

0.145

 

d)

Aggregated information

Aggregated volume Price

Aggregate Volume(s)

Volume weighted average Price) ÂŁ

124,044

0.145

 

e)

Date of the transaction

24/04/18

f)

Place of the transaction

LSE

 

Contacts:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Colin King, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

Jag Grewal, Group Sales and Marketing Director

 

 

 

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)

 

Camille Gochez (Corporate Broking)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKQDKABKDBQB
Date   Source Headline
9th Oct 20097:00 amRNSTrading Update
2nd Oct 20093:20 pmRNSHolding(s) in Company
2nd Oct 20093:04 pmRNSHolding(s) in Company
2nd Oct 200912:16 pmRNSHolding(s) in Company
2nd Oct 20098:53 amRNSHolding(s) in Company
30th Sep 20097:00 amRNSHolding(s) in Company
30th Sep 20097:00 amRNSHolding(s) in Company
25th Sep 20097:00 amRNSIssue of equity and acquisition
27th Aug 200911:56 amRNSAGM Statement
17th Jul 20099:00 amRNSAnnual Financial Report
16th Jul 20097:00 amRNSUK Distribution agreement for Genesis products
7th Jul 20097:00 amRNSFinal Results
4th Jun 20097:00 amRNSHolding(s) in Company
26th May 20097:00 amRNSLaunch of quality performance product
6th Apr 20093:03 pmRNSDirector/PDMR Shareholding
2nd Apr 200911:41 amRNSTrading Statement
20th Mar 20092:00 pmRNSChange of Adviser
12th Dec 20083:48 pmRNSDirector/PDMR Shareholding
27th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSTrading Statement
8th Oct 20083:57 pmRNSChange of Adviser Name
28th Aug 20081:24 pmRNSAGM Statement
12th Aug 200810:51 amRNSIssue of Equity / Directors'
18th Jul 200811:30 amRNSAnnual Report and Accounts
7th Jul 20087:00 amRNSFinal Results
12th Jun 20087:00 amRNSNotice of Results
10th Apr 20087:18 amRNSTrading Statement
12th Mar 200811:59 amRNSDirector/PDMR Shareholding
11th Mar 20082:19 pmRNSDirector/PDMR Shareholding
4th Mar 20087:01 amRNSDirector/PDMR Shareholding
10th Jan 20082:28 pmRNSHolding(s) in Company
7th Dec 20077:01 amRNSInterim Results
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSNotifiable Interest
3rd Sep 20078:00 amRNSCompletion of Acquisition
3rd Sep 20078:00 amRNSTotal Voting Rights
31st Aug 20071:27 pmRNSDirectors' Dealings
31st Aug 20078:21 amRNSGenesis-CNS Interim Results
31st Aug 20078:00 amRNSCancellation - 31/08/07
30th Aug 200712:56 pmRNSResult of EGM
15th Aug 20078:23 amRNSCompliance with AIM Rule 26
13th Aug 200710:22 amRNSSchedule 1 -Omega Diagnostics
8th Aug 200712:26 pmRNSAGM Statement
6th Aug 20077:01 amRNSAcquisition and placing
6th Aug 20077:00 amRNSRestoration-Omega Diagnostics
6th Aug 20077:00 amRNSChange of Adviser
12th Jul 20071:30 pmRNSStatement re. Suspension
12th Jul 20071:30 pmRNSSuspension-Omega Diagnostics
26th Jun 20077:01 amRNSFinal Results
18th Apr 20074:50 pmRNSAccounting Reference Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.